β¨ Health Notices
11 JULY 2013 NEW ZEALAND GAZETTE, No. 88 2353
Reappointments to the Medical Radiation Technologists Board
Pursuant to section 120 of the Health Practitioners Competence Assurance Act 2003, the Minister of Health reappoints
Julia Andrew
as a health practitioner member of the Medical Radiation Technologists Board for a three-year term of office; and
Jennifer de Ridder
as a health practitioner member of the Medical Radiation Technologists Board for a one-year term of office; and
Prue Lamerton
as a health practitioner member of the Medical Radiation Technologists Board for an eighteen-month term of office, all commencing on the date of publication of this notice.
Dated at Wellington this 3rd day of July 2013.
HON TONY RYALL, Minister of Health.
go4296
Medicines Act 1981
Consent to the Distribution of New Medicines
Pursuant to section 20 of the Medicines Act 1981, the Minister of Health hereby consents to the distribution in New Zealand of the new medicine set out in the Schedule hereto:
Schedule
Product: Valaciclovir Actavis 1000
Active Ingredient: Valaciclovir hydrochloride monohydrate 1223.4mg equivalent to Valaciclovir base 1000mg
Dosage Form: Film coated tablet
New Zealand Sponsor: Actavis New Zealand Limited
Manufacturer: Actavis hf., Hafnarfjordur, Iceland
Product: Valaciclovir Actavis 250
Active Ingredient: Valaciclovir hydrochloride monohydrate 305.85mg equivalent to Valaciclovir base 250mg
Dosage Form: Film coated tablet
New Zealand Sponsor: Actavis New Zealand Limited
Manufacturer: Actavis hf., Hafnarfjordur, Iceland
Product: Valaciclovir Actavis 500
Active Ingredient: Valaciclovir hydrochloride monohydrate 611.7mg equivalent to Valaciclovir base 500mg
Dosage Form: Film coated tablet
New Zealand Sponsor: Actavis New Zealand Limited
Manufacturer: Actavis hf., Hafnarfjordur, Iceland
Dated this 8th day of July 2013.
DR DON MACKIE, Chief Medical Officer, Clinical Leadership, Protection and Regulation Business Unit, Ministry of Health (pursuant to delegation given by the Minister of Health on 6 July 2001).
go4305
Consent to the Distribution of New Medicines
Pursuant to section 20 of the Medicines Act 1981, the Minister of Health hereby consents to the distribution in New Zealand of the new medicines which were referred to the Minister of Health under the provisions of section 24(5) of the Act and are set out in the Schedule hereto:
Schedule
Product: Adacel Polio
Active Ingredients:
- Diphtheria toxoid, adsorbed 2IU
- Pertactin 3mcg
- Pertussis filamentous haemagglutinin 5mcg
- Pertussis fimbriae 2+3 5mcg
- Pertussis toxoid, adsorbed 2.5mcg
- Polio virus type 1 40DAgU
- Polio virus type 2 8DAgU
- Polio virus type 3 32DAgU
- Tetanus toxoid 20IU
Dosage Form: Suspension for injection
New Zealand Sponsor: sanofi-aventis new zealand limited
Manufacturers: Sanofi Pasteur SA, Marcy LβEtoile, France
Sanofi Pasteur Limited, Ontario, Canada
Next Page →
β¨ LLM interpretation of page content
π₯ Reappointments to the Medical Radiation Technologists Board
π₯ Health & Social Welfare3 July 2013
Reappointments, Medical Radiation Technologists Board, Health Practitioner Members
- Julia Andrew, Reappointed as health practitioner member
- Jennifer de Ridder, Reappointed as health practitioner member
- Prue Lamerton, Reappointed as health practitioner member
- HON TONY RYALL, Minister of Health
π₯ Consent to the Distribution of New Medicines
π₯ Health & Social Welfare8 July 2013
Medicines, Distribution, Valaciclovir, Actavis
- DR DON MACKIE, Chief Medical Officer, Clinical Leadership, Protection and Regulation Business Unit, Ministry of Health
π₯ Consent to the Distribution of New Medicines
π₯ Health & Social Welfare8 July 2013
Medicines, Distribution, Adacel Polio, Sanofi Pasteur
- DR DON MACKIE, Chief Medical Officer, Clinical Leadership, Protection and Regulation Business Unit, Ministry of Health
NZ Gazette 2013, No 88